Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Coca-Cola Enterprises Inc

Article Abstract:

Coca-Cola Enterprises Inc (CCE) projects that earnings in FY 1992 will not be better than 15 cents a share. CCE is a Coca-Cola bottler valued at US$4 billion. The financial sector is bothered that the low projection is below estimates of 18 cents a share. Analysts believe CCE's stocks will no longer be viable and expect investors to sell the securities. A CCE director, Claus M. Halle, thinks otherwise. Halle purchased an additional 9,000 shares at 14-1/8 to increase his holdings to 10,000 shares. CCE has declared a dividend of 5 cents on its 115 million shares.

Publisher: Thomson Financial Inc.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
Bottled and canned soft drinks, Securities, Coca-Cola Enterprises Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nature's Sunshine Products, Inc

Article Abstract:

Nature's Sunshine Products Inc (NATR) projects a $100 million sales for the year 1992. This is a $10 million increase from the target sales estimated by analysts. NATR's optimism evolves from the success of its recruitment of distributors, consumer acceptance of herbs and alternative health care and the wider response of European and Latin American consumers to their products.

Publisher: Thomson Financial Inc.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
Service industry machinery, not elsewhere classified, Medicinals and botanicals, Drugs, proprietaries, and sundries, Forecasts and trends, Health products industry, Health care products industry, Nature's Sunshine Products Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: COR Therapeutics, Inc. Noven Pharmaceuticals Inc. McKesson Corp
  • Abstracts: SEI Corp. Duff and Phelps credit R - DCR
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.